Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11.
With dermatologic side effects being fairly prevalent following vaccination against COVID-19, and the multitude of studies aiming to report and analyze these adverse events, the need for an extensive investigation on previous studies seemed urgent, in order to provide a thorough body of information about these post-COVID-19 immunization mucocutaneous reactions. To achieve this goal, a comprehensive electronic search was performed through the international databases including Medline (PubMed), Scopus, Cochrane, Web of science, and Google scholar on July 12, 2021, and all articles regarding mucocutaneous manifestations and considerations after COVID-19 vaccine administration were retrieved using the following keywords: COVID-19 vaccine, dermatology considerations and mucocutaneous manifestations. A total of 917 records were retrieved and a final number of 180 articles were included in data extraction. Mild, moderate, severe and potentially life-threatening adverse events have been reported following immunization with COVID vaccines, through case reports, case series, observational studies, randomized clinical trials, and further recommendations and consensus position papers regarding vaccination. In this systematic review, we categorized these results in detail into five elaborate tables, making what we believe to be an extensively informative, unprecedented set of data on this topic. Based on our findings, in the viewpoint of the pros and cons of vaccination, mucocutaneous adverse events were mostly non-significant, self-limiting reactions, and for the more uncommon moderate to severe reactions, guidelines and consensus position papers could be of great importance to provide those at higher risks and those with specific worries of flare-ups or inefficient immunization, with sufficient recommendations to safely schedule their vaccine doses, or avoid vaccination if they have the discussed contra-indications.
由于 COVID-19 疫苗接种后出现皮肤不良反应相当普遍,而且有许多研究旨在报告和分析这些不良事件,因此需要对以前的研究进行广泛调查,以便提供关于这些 COVID-19 免疫后黏膜皮肤反应的全面信息。为了实现这一目标,我们于 2021 年 7 月 12 日通过国际数据库(包括 Medline(PubMed)、Scopus、Cochrane、Web of science 和 Google scholar)进行了全面的电子搜索,并使用以下关键词检索了所有关于 COVID-19 疫苗接种后黏膜皮肤表现和注意事项的文章:COVID-19 疫苗、皮肤病学注意事项和黏膜皮肤表现。共检索到 917 条记录,最终有 180 篇文章纳入数据提取。通过病例报告、病例系列、观察性研究、随机临床试验以及进一步的疫苗接种建议和共识立场文件,报告了 COVID 疫苗接种后出现轻度、中度、重度和潜在危及生命的不良事件。在本系统评价中,我们将这些结果详细分类到五个详细的表格中,形成了我们认为是关于这个主题的广泛而有信息量的、前所未有的数据集。根据我们的发现,从疫苗接种的利弊来看,黏膜皮肤不良反应大多是非显著性、自限性反应,对于更常见的中度至重度反应,指南和共识立场文件可能非常重要,为那些高风险人群以及那些对爆发或免疫效率低下有特定担忧的人群提供充分的建议,以安全地安排他们的疫苗剂量,或在有讨论的禁忌症的情况下避免接种疫苗。